Close Menu

Waters

Minneapolis – Thermo Fisher Scientific made a splash at this week's American Society of Mass Spectrometry annual meeting with the launch of its hi-res Fusion instrument (

New Products: ASMS 2013 Focus

Premium

A number of vendors introduced new proteomics products at the American Society for Mass Spectrometry meeting in Minneapolis this week. The following is a roundup of new offerings introduced at the conference.

Agilent this week introduced its AdvanceBio Peptide Mapping BioHPLC and ZORBAX RRHD 300-HILIC columns for the analysis of proteins, monoclonal antibodies, peptides and additional biologics.

Bruker's shareholders have re-elected its class 1 directors to serve until the company's 2016 shareholder meeting, including Wolf-Dieter Emmerich; Brenda Furlong; Frank Laukien; and Richard Packer.

NEW YORK (GenomeWeb News) – Waters today reported that its revenues in the first quarter were up 2 percent year over year, driven by a resurgence in instrument sales, particularly mass spectrometers.

Waters announced this week that it has named the St. John's Research Institute in Bangalore, India, a Center of Excellence.

Thermo Fisher Scientific said this week that two of its facilities have achieved ISO 13485 certification, moving the company forward in its efforts to develop liquid chromatography-mass spectrometry systems for clinical use.

VICAM, a business of Waters, this week introduced its new Myco6in1+ LC/MS/MS immunoaffinity column for detection of mycotoxins.

Bruker last week introduced its benchtop Compact LC-QqTOF mass spectrometer.

Proteomics research continues to be a booming business in China, with the market over the last few years having grown at around 30 percent to 35 percent annually, according to estimates from biotech consulting firm JZMed.

Pages

The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.

The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.

New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.

In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.